| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 09/18/2001 | US6291457 Compounds having cytokine inhibitory activity |
| 09/13/2001 | WO2001066140A1 Use of tgf-beta antagonists to treat or to prevent loss of renal function |
| 09/13/2001 | WO2001066107A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 09/13/2001 | WO2001066106A1 A pharmaceutical composition having chlorogenic acid as active component for preventing or treating the declining of male reproduction capability |
| 09/13/2001 | WO2001030759A3 Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 09/13/2001 | US20010021758 Drugs, medical diagnosis |
| 09/13/2001 | CA2401323A1 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 09/13/2001 | CA2400628A1 Use of tgf-beta antagonists to treat or to prevent loss of renal function |
| 09/12/2001 | EP1132089A1 Extract from loquat seeds against fibrosis |
| 09/12/2001 | EP1131314A1 Compounds having cytokine inhibitory activity |
| 09/12/2001 | EP1131103A1 Stable amorphous amifostine compositions and methods for the preparation and use of same |
| 09/12/2001 | EP1131090A2 Method of using pon-1 to decrease atheroma formation |
| 09/12/2001 | EP1131039A2 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress |
| 09/12/2001 | EP0831864B1 Processed ginseng having enhanced pharmacological effect |
| 09/12/2001 | CN1312715A Antihypersensitive combination of valsartan and calcium channel blocker |
| 09/12/2001 | CN1070701C Pyrimidine ortriazine carboxylic acid derivatives to be used as medicaments |
| 09/11/2001 | US6288028 BPC peptide salts with organo-protective activity, the process for their preparation and their use in therapy |
| 09/07/2001 | WO2001064661A1 Antioxidants |
| 09/07/2001 | WO2001064220A1 Use of trimetazidine to inhibit acyl-coa acetyl transferase |
| 09/07/2001 | WO2001064204A2 Composition for the prevention and/or treatment of the cytotoxic effects induced by the use of immunosuppressive agents |
| 09/07/2001 | WO2001064165A2 Il-8 receptor antagonists |
| 09/07/2001 | WO2001019823A3 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 09/05/2001 | EP1129086A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 09/05/2001 | CN1311674A Antioxidant, antiproliferous compositions, comprising a carnitine and a cerotenoid |
| 09/05/2001 | CN1310998A Composite coenzyme Q10 medicine |
| 09/05/2001 | CN1070370C Crystalline amifostine compositions and process for prepn. of same and use thereof |
| 09/04/2001 | US6284725 Administering binding compound for glucagon receptor such asglucagon-like peptide |
| 09/04/2001 | US6284268 Cyclosporin, synergistic |
| 09/04/2001 | US6284258 Long-acting, chemical-resistant skin emollients, moisturizers, and strengtheners |
| 08/30/2001 | WO2001062744A2 Substituted piperazine compounds |
| 08/30/2001 | WO2001062736A1 Aryl fused azapolycyclic compounds |
| 08/30/2001 | WO2001062262A1 Compounds with chelation affinity and selectivity for first transition series elements and their use |
| 08/30/2001 | WO2001062223A2 Cosmetic preparations containing plant extracts |
| 08/30/2001 | WO2001012127A3 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 08/30/2001 | US20010018447 Il-8 receptor antagonists |
| 08/30/2001 | US20010018068 Water insoluble substrate comprising creped nonwoven layer and cleansing component (lathering surfactant); cleaning/ conditioning skin/hair; disposable; materials handling |
| 08/30/2001 | CA2657986A1 Substituted piperazine compounds |
| 08/29/2001 | EP1127136A1 Delivery of superoxide dismutase to neuronal cells |
| 08/29/2001 | EP1127132A1 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| 08/29/2001 | EP1127058A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 08/29/2001 | EP1126855A1 Methods for preventing/treating damage to sensory hair cells and cochlear neurons |
| 08/29/2001 | CN1310610A Pharmaceutical composition in particular for preventing and treating mucositis induced by radiotherapy or chemotherapy |
| 08/29/2001 | CN1309970A Application of uridine phosphorylase inhibitor and composition containing the same |
| 08/29/2001 | CN1070176C 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceuticals |
| 08/29/2001 | CN1070059C Medicinal liquor and its prodn. method |
| 08/23/2001 | WO2001060378A2 Antiadhesive carbohydrates |
| 08/23/2001 | WO2001060349A2 Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof. |
| 08/23/2001 | WO2001012775A3 25 human secreted proteins |
| 08/23/2001 | US20010016592 Novel diamine alkylene diacetic or triacetic acid derivatives, preparation method, use in cosmetic and pharmaceutical compositions and compositions containing them |
| 08/23/2001 | US20010016590 Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol |
| 08/23/2001 | DE10006989A1 Pharmaceutical or dietetic preparation for preventing cellular adhesion of pathogens, e.g. in treatment of infections, comprising carbohydrate having double bond-containing terminal uronic acid unit |
| 08/23/2001 | CA2765218A1 Antiadhesive carbohydrates comprising a terminal uronic acid unit containing a carbon-carbon double bond |
| 08/22/2001 | EP1124983A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids |
| 08/22/2001 | EP1124980A2 Method for the production of quercetin and isoquercetin derivatives |
| 08/22/2001 | EP1124815A1 Method for producing luteolin and luteolin derivatives |
| 08/22/2001 | EP1124801A1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 08/22/2001 | EP1124576A2 Method for preparing solid phase conjugate vaccines |
| 08/22/2001 | EP0752854B1 Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments |
| 08/22/2001 | CN1309563A Use of 1-(aminoalkyl)-3-quinoxaline-2-one derives for preparation of compounds having antioxidant action |
| 08/22/2001 | CN1308940A Application and preparing process of nm-class biological medical stone powder |
| 08/16/2001 | WO2001059067A2 A group of anti-cancer compounds with specific structure and their production method |
| 08/16/2001 | WO2001058956A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | WO2001058881A1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 08/16/2001 | WO2001058451A1 Tamper-resistant oral opioid agonist formulations |
| 08/16/2001 | WO2001058447A1 Controlled-release compositions containing opioid agonist and antagonist |
| 08/16/2001 | WO2001058412A2 Extracts from residues left in the production of wine |
| 08/16/2001 | WO2001058241A2 Adenosine a2a receptor antagonists for treating and preventing hepatic fibrosis, cirrhosis and fatty liver |
| 08/16/2001 | WO2000039104A9 Phenazine compounds, methods and pharmaceutical compositions for inhibiting parp |
| 08/16/2001 | DE10004858A1 Verwendung von Proteinkinase-Inhibitor-alpha The use of protein kinase inhibitor alpha- |
| 08/16/2001 | CA2800450A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2399148A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2398923A1 A group of anti-cancer compounds with specific structure and their production method |
| 08/15/2001 | CN1307872A Selenium product of natural marine organism and its preparation |
| 08/15/2001 | CN1307870A Crystallized pirimiphos-methyl composite and its preparation and usage |
| 08/09/2001 | WO2001056590A2 Utilization of protein kinase inhibitor alpha |
| 08/09/2001 | WO2001056588A1 Phytotherapeutic composition for eliminating heavy metals |
| 08/09/2001 | WO2001010901A3 Antimicrobial histone h1 compositions, kits, and methods of use thereof |
| 08/09/2001 | WO2000075144A8 Peroxynitrite decomposition catalysts and methods of use thereof |
| 08/09/2001 | WO2000074729A3 Alpha or beta emitters to fragments in radioimmunotherapy |
| 08/09/2001 | WO2000069895A3 Bufornin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins |
| 08/09/2001 | DE10003493A1 Preparing complexes of cyclodextrin and coenzyme Q10, are useful for treating cardiac or degenerative diseases, by homogenizing starting materials with an input of energy |
| 08/08/2001 | EP1121106A1 Treatment of dyspepsia |
| 08/08/2001 | EP0815112B1 Process for isolating galanthamine |
| 08/08/2001 | CN1307487A Method of treating endotoxemia |
| 08/08/2001 | CN1306843A Capsule with senility-delaying function and its preparation |
| 08/07/2001 | US6271374 Stable crystalline (6S)- and (6R)-tetrahydrofolic acid |
| 08/07/2001 | US6270776 Recombinant mycobacterial vaccine |
| 08/07/2001 | US6270769 Providing the antigen to which the ctl response is desired and providing an antigen formulation which consists of two or more of a stabilizing detergent, a micelle-forming agent, and an oil; antigen lacking an immunostimulating peptide component |
| 08/07/2001 | US6270747 Inhibiting hypersecretion of mucus in lungs and airways by the administration of an egf-r antagonist. |
| 08/04/2001 | CA2298041A1 Biocompatible, injectable aqueous solution for use in ultrasound energy assisted surgery |
| 08/02/2001 | WO2001054730A1 METHOD FOR PRODUCING A COENZYME Q10 / η-CYCLODEXTRIN COMPLEX |
| 08/02/2001 | WO2001054667A1 Electrospun pharmaceutical compositions |
| 08/02/2001 | US20010010935 Useful in treating stem cells in a patient undergoing chemotherapy |
| 08/02/2001 | CA2396640A1 Electrospun pharmaceutical compositions |
| 08/01/2001 | EP1119573A2 Bipyridine manganese complexes |
| 08/01/2001 | EP1119553A1 Monomeric and dimeric heterocycles, and therapeutic uses thereof |
| 08/01/2001 | EP1119349A2 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 08/01/2001 | EP0885013B1 Use of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses for the preparation of medicaments |
| 08/01/2001 | CN1306576A G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 08/01/2001 | CN1306423A Use of nitric oxide scavengers to treat side effects caused by therapeutic administration of sources of nitric oxide |